Literature DB >> 3588256

Increased plasma calcitonin levels in young spontaneously hypertensive rats: role in disturbed phosphate homeostasis.

R J Bindels, L A van den Broek, M J Jongen, W H Hackeng, C W Löwik, C H van Os.   

Abstract

In young spontaneously hypertensive rats (SHR) and in normotensive Wistar-Kyoto controls (WKY) several parameters of phosphate and calcium homeostasis were determined. At 6 and 8 weeks, blood analysis revealed a significant hypophosphatemia (p less than 0.001) in SHR and twice as high plasma calcitonin levels in SHR than in WKY controls. At 8 weeks, 1,25-dihydroxycholecalciferol concentration was 20% higher in SHR (p less than 0.02) while 25-hydroxycholecalciferol was unaltered (p greater than 0.51). In addition total immunoreactive PTH, iPTH, was slightly increased (p less than 0.07) but intact PTH (1-84) (p greater than 0.90) was not significantly different from age matched WKY controls. Also at 8 weeks, a slightly reduced serum ionized Ca2+ concentration (p less than 0.001) with no change in total serum calcium was found in SHR (p greater than 0.39). Balance studies at 6 and 8 weeks of age revealed no significantly different balances for phosphate (F = 2.5, p greater than 0.10) and for calcium (F = 2.6, p greater than 0.09), although a tendency for slightly more positive balances existed in SHR when compared to WKY. However, SHR excreted significantly less phosphate in the urine than WKY control (F = 0.2, p less than 0.0009). Bone analysis was performed on femora of SHR and WKY of 6 weeks of age. Femora were significantly shorter in SHR (20.54 +/- 0.35 vs. 21.50 +/- 0.05 mm in WKY), whereas bone dry weight (127 +/- 6 vs. 107 +/- 2 mg).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3588256     DOI: 10.1007/bf00581135

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  28 in total

1.  Clinical implications of estimation of intact parathyroid hormone (PTH) versus total immunoreactive PTH in normal subjects and hyperparathyroid patients.

Authors:  W H Hackeng; P Lips; J C Netelenbos; C J Lips
Journal:  J Clin Endocrinol Metab       Date:  1986-08       Impact factor: 5.958

2.  Serum phosphate inversely related to blood pressure.

Authors:  S Ljunghall; H Hedstrand
Journal:  Br Med J       Date:  1977-02-26

3.  Renal handling of phosphate.

Authors:  C L Mizgala; G A Quamme
Journal:  Physiol Rev       Date:  1985-04       Impact factor: 37.312

4.  Effect of phosphate deprivation on phosphate reabsorption in rat nephron: role of PTH.

Authors:  E Pastoriza-Muñoz; D R Mishler; C Lechene
Journal:  Am J Physiol       Date:  1983-02

5.  Transport of calcium by duodenum of spontaneously hypertensive rat.

Authors:  M A Toraason; G L Wright
Journal:  Am J Physiol       Date:  1981-10

6.  Enhanced parathyroid function in essential hypertension: a homeostatic response to a urinary calcium leak.

Authors:  D A McCarron; P A Pingree; R J Rubin; S M Gaucher; M Molitch; S Krutzik
Journal:  Hypertension       Date:  1980 Mar-Apr       Impact factor: 10.190

7.  Renal phosphate excretion in spontaneously hypertensive and normotensive Wistar Kyoto rats.

Authors:  C H Hsu; P S Chen; R M Caldwell
Journal:  Kidney Int       Date:  1984-05       Impact factor: 10.612

8.  Evidence against the role of calcium deficiency in genetic hypertension.

Authors:  K Lau; U Gafter; D Rydell; B Eby; M Pesigan; I Tropp; J Garno; D Zikos
Journal:  Hypertension       Date:  1986-01       Impact factor: 10.190

9.  Abnormal vitamin D metabolism, intestinal calcium transport, and bone calcium status in the spontaneously hypertensive rat compared with its genetic control.

Authors:  P A Lucas; R C Brown; T Drüeke; B Lacour; J A Metz; D A McCarron
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

10.  The concentrations of ionic and total calcium in plasma of the spontaneously hypertensive rat.

Authors:  G L Wright; M A Toraason; J S Barbe; W Crouse
Journal:  Can J Physiol Pharmacol       Date:  1980-12       Impact factor: 2.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.